Urogen Pharma(GB:0XOD)
$25.99+0.67 (+2.65%)
GB:0XOD
Urogen Pharma hedge funds
$25.99
At close:+0.67 (+2.65%)
Urogen Pharma (0XOD) Hedge Fund Trading Activity
1 Followers
Trend: ▲ Hedge Funds Increased Holdings by 28.8K Shares Last Quarter
Hedge Fund Holdings in 0XOD
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Aisling Capital Management LP | New | 100.00% | $2,529,360 | 0.53% | |||
| Woodline Partners LP | Added | 63.44% | $11,727,002 | 0.05% | |||
| Farallon Capital Management, L.L.C. | Not Changed | 0.00% | $257,620 | <0.01% | |||
| ARK Investment Management LLC | Reduced | -4.13% | $2,845,155 | 0.02% | |||
| Graham Capital Management, L.P. | Sold Out | -100.00% | $552,032 | 0.00% | |||
| Robert Bender&Associates | Sold Out | -100.00% | ― | 0.00% |
FAQ
Which hedge funds hold Urogen Pharma?
The hedge funds that hold the most shares in Urogen Pharma are Michael Rockefeller, Cathie Wood and Dennis J Purcell.
Are hedge funds buying or selling GB:0XOD?
In the last quarter hedge funds have Increased their holdings in Urogen Pharma by 28.8K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Urogen Pharma stock?
Warren Buffet currently does not own shares in Urogen Pharma.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

